Nimptsch, Katharina
Aleksandrova, Krasimira
Pham, Thu Thi
Papadimitriou, Nikos
Janke, Jürgen
Christakoudi, Sofia
Heath, Alicia
Olsen, Anja
Tjønneland, Anne
Schulze, Matthias B.
Katzke, Verena
Kaaks, Rudolf
van Guelpen, Bethany
Harbs, Justin
Palli, Domenico
Macciotta, Alessandra
Pasanisi, Fabrizio
Yohar, Sandra Milena Colorado
Guevara, Marcela
Amiano, Pilar
Grioni, Sara
Jakszyn, Paula Gabriela
Figueiredo, Jane C.
Samadder, N. Jewel
Li, Christopher I.
Moreno, Victor
Potter, John D.
Schoen, Robert E.
Um, Caroline Y.
Weiderpass, Elisabete
Jenab, Mazda
Gunter, Marc J.
Pischon, Tobias
Funding for this research was provided by:
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC)
Article History
Received: 6 March 2023
Accepted: 4 October 2023
First Online: 13 October 2023
Declarations
:
: The EPIC cohort was conducted in accordance with the Declaration of Helsinki and received ethical approval from the ethics review board of the International Agency for Research on Cancer (IARC, Lyon, France) as well as local review boards in each participating country. Participants provided written informed consent. This research project has been approved by the EPIC Steering Committee (Ref# 120911b) and ethical clearance was provided by the IARC Ethics Committee (Ref# 20-15).
: Not applicable.
: Marc J. Gunter is a member of the editorial board for <i>BMC Medicine</i>. The other authors declare no potential conflicts of interest.